Home/Filings/4/0001493152-20-012574
4//SEC Filing

Dexter Susan 4

Accession 0001493152-20-012574

CIK 0001106838other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 6:20 PM ET

Size

5.1 KB

Accession

0001493152-20-012574

Insider Transaction Report

Form 4
Period: 2020-07-02
Dexter Susan
Chief Technical Officer
Transactions
  • Award

    Common Stock

    2020-07-02+73,61373,613 total
Footnotes (1)
  • [F1]On July 2, 2020, the Reporting Person was granted 73,613 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001806764

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:20 PM ET
Size
5.1 KB